ASX:CHM – Strategic $6.6M Capital Raise to Accelerate Clinical Trial Development
Chimeric Therapeutics has secured significant funding through a strongly supported placement, demonstrating market confidence in its innovative cell therapy programs.…
No financial advise, DYOR
Chimeric Therapeutics has secured significant funding through a strongly supported placement, demonstrating market confidence in its innovative cell therapy programs.…
Zoono Group Limited (ASX: ZNO) announces a transformative exclusive agreement with Sharpak Aylesham Limited and OSY Group Limited, marking a…
23 April 2025 – Osmond Resources Limited (ASX: OSM) has announced significant advancements at its Orion EU Critical Minerals Project…
Headline estimates of employment, unemployment, underemployment, participation and hours worked from the monthly Labour Force Survey Reference period: June 2022…
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.